MedPath

The effect of expanded applied contact precaution in Mixed Intensive Care Unit of Surgical & Internal medicine: a prospective observational study

Not Applicable
Conditions
Critically Ill Patients in Intensive Care Unit
Registration Number
JPRN-UMIN000028686
Lead Sponsor
Fukuyama City Hospital Department of Anesthesiology
Brief Summary

There was no significant difference in the incidence compared to historical control (1.3 vs. 1.4 cases per 1,000 patient days). However, there was significant difference in the incidence of newly acquired multi-drug resistant bacteria between patients who adapted our rules of contact precautions and patients who did not adapted them (ex. after scheduled operation) (12.26 vs. 3.24 cases per 1,000 patient days).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
577
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome is the incidence of newly acquired MRSA in ICU.
Secondary Outcome Measures
NameTimeMethod
Secondary Outcomes are the incidence of newly acquired MRSA for 30 days after discharge from ICU, and the incidence of newly acquired multidrug-resistant bacteria in the patients who adapted our rules during ICU stay. The rules we made were to apply contact precaution not only to patients who had multidrug-resistant bacteria, but also to patients who entered ICU emergency, patients with history of infection of multidrug-resistant bacteria and patients who had to stay in ICU for a long time. Another rules started from this study period were to avoid using shared items among patients as much as possible (use disposable items), and to use a method that all of the patients had to been touched with properly disinfected "clean hands" without hand roughness. Data of patients who admitted in our ICU from May 2013 to December 2015 were used as Historical Control.
© Copyright 2025. All Rights Reserved by MedPath